|
Volumn 15, Issue 2, 2010, Pages 114-115
|
Patients with rheumatoid arthritis may benefit from a standardised powder of Rosa canina (rose hip)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HERBACEOUS AGENT;
LITOZIN;
PLACEBO;
UNCLASSIFIED DRUG;
ADULT;
CLINICAL EFFECTIVENESS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DENMARK;
DISABILITY;
DISEASE ACTIVITY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FALSE NEGATIVE RESULT;
GERMANY;
HEALTH ASSESSMENT QUESTIONNAIRE;
HUMAN;
MAJOR CLINICAL STUDY;
MEDICINAL PLANT;
NOTE;
OUTPATIENT DEPARTMENT;
PAIN ASSESSMENT;
POWDER;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
RHEUMATOID ARTHRITIS;
RISK ASSESSMENT;
ROSA CANINA;
TREATMENT DURATION;
|
EID: 77954131484
PISSN: 14653753
EISSN: None
Source Type: Journal
DOI: 10.1211/fact.15.2.0010 Document Type: Note |
Times cited : (2)
|
References (5)
|